Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus

Lupus

Volumn 16, Issue 5, 2007, Pages 324-328

  Tarr, T ^a   Lakos, G ^a   Bhattoa, H P ^b   Szegedi, G ^c   Shoenfeld, Y ^d   Kiss, Emese ^a,b  

^a Third Department of Internal Medicine   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Association; PAPS; SLE

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; FETUS WASTAGE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSIENT ISCHEMIC ATTACK;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 34447515680     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307077993     Document Type: Article

References (18)

1. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1743.
2. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
3. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46: 1019-1027.
4. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
5. Mujic F, Cuadrado MJ, Lloyd M, Khamashta MA, Page G, Hughes GR: Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995; 22: 1589-1598.
6. Derksen R, Gmeling-Meijling F, deGroot PhG. Case Report. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus 1996; 5: 77-80.
7. Gomez-Puerta JA, Martin H, Amigo MC et al. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 2005; 84: 225-230.
8. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
9. Miyakis S, Lockshin MD, Astumi T et al. International consensus statemnet on an update of the classification criteria dor definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
11. Lakos G, Kiss E, Regeczy N et al. Isotype distribution and clinical relevance of anti-beta2-glycoproteinI antibodies: importance of IgA isotype. Clin Exp Immunol 1999; 117: 574-579.
12. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-1190.
13. Bowie EJ, Thompson HJ Jr, Pascuzzi CA, Owren CA Jr. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430.
14. Asherson RA, Piette J-C, Cervera R. "Primary", "Secondary", "Seronegative", "Catastrophic" and other subsets of the antiphospholipid syndrome. In Asherson RA, Cervera R, Piette J-C, Shoenfeld Y eds. The antiphospholipid syndrome II: Autoimmune thrombosis. Elsevier Science, 2002: 285-296.
15. Soltesz P, Veres K, Lakos G, Kiss E, Muszbek L, Szegedi G. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients. Lupus 2003; 12: 302-307.
16. Asherson RA, Shoenfeld Y. The significance of antibodies to DNA in the primary antiphospholipid syndrome. Clin Exp Rheumatol 1994; 12: 1-3.
17. McClain MT, Arbuckle MR, Heinlen LD et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004; 50: 1226-1232.
18. Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 975-981.